Aprogen Medicines Inc. (007460.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 229.48B |
| Enterprise Value | 372.19B |
| P/E Ratio | -0.07 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0.02 |
| Price/Book Ratio | 0.81 |
| Enterprise/Revenue | 1.06 |
| Enterprise/EBITDA | -1.21 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.6 |
| Operating Margin | -0.72 |
| Return On Assets | -0.12 |
| Return On Equity | -0.64 |
| Revenue | 117.97B |
| Revenue/Share | 6,433.57 |
| Gross Profit | 33.24B |
| EBITDA | -113.95B |
| Net Income | -69.48B |
| Diluted EPS | -52,533.75 |
| Total Cash | 43.16B |
| Total Cash/Share | 1,999.21 |
| Total Debt | 181.45B |
| Total Debt/Equity | 3 |
| Current Ratio | 0.83 |
| Book Value Per Share | 19,199.49 |
| 52-Week Change | -98.52 |
| 52-Week High | 14,062.97 |
| 52-Week Low | 1,961 |
| Moving Average 50 Days | 2,497 |
| Moving Average 200 Days | 6,177 |
| Average Volume | 159,743 |
| Shares Outstanding | 1.4M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | 1:15 |
| Last Split Date | May 08, 2026 |